Israel Biotech Fund
Murray A. Goldberg is a Venture Advisor at Israel Biotech Fund. Murray has financial and operational experience at leading global pharmaceutical companies. Murray served as Senior Vice President-Administration and Chief Financial Officer of Regeneron Pharmaceuticals (NASDAQ: REGN), Chief Financial Officer, Treasurer & VP-Finance of PharmaGenics, Inc., and as a Managing Director-Structured Finance Group of The Chase Manhattan Bank NA.
He currently serves as a director at Teva Pharmaceutical (NASDAQ: TEVA) and at Aerie Pharmaceuticals (NASDAQ: AERI). Murray received his undergraduate degree from New York University, a graduate degree from the London School of Economics & Political Science, and an MBA from the University of Chicago.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Israel Biotech Fund
Israel Biotech Fund seeks high-value returns by identifying and maximizing the success of therapeutic assets of Israel-based biotech companies. Their key asset is a unique team of 25 Venture Advisors, comprised of renowned industry leaders and professionals who, together with the fund’s managing partners, provide their portfolio companies with hands-on guidance and support.